MediMergent: The Real-World Evidence Company
Without RWD, Especially The Voice Of The Patient, Stakeholders Are Working Blind
MediMergent Collaborates with FDA On Real-World Evidence
Under a Research Collaboration Agreement with the U.S. Food and Drug Administration, MediMergent designed and currently deploys it’s proprietary platform to collect RWD and validate rules-based analytic processes. The collaboration focuses on: traditional and non-traditional data sources including wearable devices and digital apps; processes to standardize, correlate and integrate structured and unstructured data; and algorithms to bring transparency to siloed data.